Tech Company Financing Transactions
OncoFusion Therapeutics Funding Round
On 3/2/2013, OncoFusion Therapeutics landed $525 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
3/2/2013
Transaction Type
Debt
Amount
$525,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1600 Huron Pkwy. 2nd Floor
Ann Arbor, MI 48109
USA
Ann Arbor, MI 48109
USA
Phone
Website
Email Address
Not Recorded
Overview
OncoFusion Therapeutics, Inc. (Ann Arbor, MI) is an oncology discovery and development company targeting gene fusions that are thought to drive many common cancers. The technology is based on discoveries from the laboratories of the companies' co-founders, Dr. Arul Chinnaiyan and Dr. Shaomeng Wang, at the University of Michigan.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Mel Sorensen
Chief Scientific Officer
Shaomeng Wang
Co-Founder
Arul Chinnaiyan
Browse more venture capital transactions:
Prev: 3/2/2013: Marxent venture capital transaction
Next: 3/4/2013: Rennovia venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs